CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Amicus Therapeutics, Inc Company Snapshot
Amicus Therapeutics, Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amicus Therapeutics, Inc with three other companies in this sector in the United States: Orexo Ab (2018 sales of $89.68 million of which 79% was Zubsolv), Agios Pharmaceuticals Inc ($94.39 million of which 100% was Bio-Pharmaceutical), and Athenex Inc ($89.10 million of which 37% was Oncology Innovation Platform).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Amicus Therapeutics, Inc
  Stock Performance Chart for Amicus Therapeutics, Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 8.94
(Figures in U.S. Dollars)
1 Week 1.7%   13 Weeks 13.8%  
4 Weeks -17.4%   52 Weeks -15.6%  
 
Amicus Therapeutics, Inc Key Data:
  Ticker: FOLD Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 91,245,000
(Year Ending Jan 2019).
Employees: 508
  Currency: U.S. Dollars Market Cap: 2,276,357,003
  Fiscal Yr Ends: December Shares Outstanding: 254,626,063
  Share Type: Common Closely Held Shares: 2,194,452
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.